Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration
- PMID: 20688744
- DOI: 10.1167/iovs.09-4995
Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration
Abstract
Purpose: To evaluate the functional effect of short-term supplementation of saffron, a spice containing the antioxidant carotenoids crocin and crocetin, in early age-related macular degeneration (AMD).
Methods: Twenty-five patients with AMD were randomly assigned to oral saffron 20 mg/d or placebo supplementation over a 3-month period and then reverted to placebo or saffron for a further 3 months. Focal electroretinograms (fERGs) and clinical findings were recorded at baseline and after 3 months of saffron or placebo supplementation. fERGs were recorded in response to a sinusoidally modulated (41 Hz), uniform field presented to the macular region (18°) at different modulations between 16.5% and 93.5%. Main outcome measures were fERG amplitude (in microvolts), phase (in degrees), and modulation thresholds.
Results: After saffron, patients' fERGs were increased in amplitude, compared with either baseline or values found after placebo supplementation (mean change after saffron, 0.25 log μV; mean change after placebo, -0.003 log μV; P < 0.01). fERG thresholds were decreased after saffron supplementation but not placebo, compared with baseline (mean change after saffron, -0.26 log units; mean change after placebo, 0.0003 log units).
Conclusions: The results indicate that short-term saffron supplementation improves retinal flicker sensitivity in early AMD. Although the results must be further replicated and the clinical significance is yet to be evaluated, they provide important clues that nutritional carotenoids may affect AMD in novel and unexpected ways, possibly beyond their antioxidant properties. (ClinicalTrials.gov number, NCT00951288.).
Similar articles
-
Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial.Graefes Arch Clin Exp Ophthalmol. 2019 Jan;257(1):31-40. doi: 10.1007/s00417-018-4163-x. Epub 2018 Oct 20. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 30343354 Clinical Trial.
-
Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year.Ophthalmology. 2008 Feb;115(2):324-333.e2. doi: 10.1016/j.ophtha.2007.05.029. Epub 2007 Aug 22. Ophthalmology. 2008. PMID: 17716735 Clinical Trial.
-
Saffron and retina: neuroprotection and pharmacokinetics.Vis Neurosci. 2014 Sep;31(4-5):355-61. doi: 10.1017/S0952523814000108. Epub 2014 May 12. Vis Neurosci. 2014. PMID: 24819927 Review.
-
Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy.Nutrients. 2019 Oct 15;11(10):2461. doi: 10.3390/nu11102461. Nutrients. 2019. PMID: 31618812 Free PMC article. Clinical Trial.
-
Rescue of retinal function by macular translocation surgery in age-related macular degeneration and other diseases with subfoveal choroidal neovascularization.Nagoya J Med Sci. 2001 May;64(1-2):1-9. Nagoya J Med Sci. 2001. PMID: 11486596 Review.
Cited by
-
Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial.Graefes Arch Clin Exp Ophthalmol. 2019 Jan;257(1):31-40. doi: 10.1007/s00417-018-4163-x. Epub 2018 Oct 20. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 30343354 Clinical Trial.
-
Discovering the Potential of Natural Antioxidants in Age-Related Macular Degeneration: A Review.Pharmaceuticals (Basel). 2022 Jan 14;15(1):101. doi: 10.3390/ph15010101. Pharmaceuticals (Basel). 2022. PMID: 35056157 Free PMC article. Review.
-
Pharmacological Effects of Saffron and its Constituents in Ocular Disorders from in vitro Studies to Clinical Trials: A Systematic Review.Curr Neuropharmacol. 2021;19(3):392-401. doi: 10.2174/1570159X18666200507083346. Curr Neuropharmacol. 2021. PMID: 32379589 Free PMC article.
-
Short-term Outcomes of Saffron Supplementation in Patients with Age-related Macular Degeneration: A Double-blind, Placebo-controlled, Randomized Trial.Med Hypothesis Discov Innov Ophthalmol. 2016 Spring;5(1):32-38. Med Hypothesis Discov Innov Ophthalmol. 2016. PMID: 28289690 Free PMC article.
-
Saffron and its active ingredients against human disorders: A literature review on existing clinical evidence.Iran J Basic Med Sci. 2022 Aug;25(8):913-933. doi: 10.22038/IJBMS.2022.63378.13985. Iran J Basic Med Sci. 2022. PMID: 36159329 Free PMC article. Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical